Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity during Risky Decision Making

Neuropsychopharmacology

Volumn 41, Issue 3, 2016, Pages 695-703

  Kohno, Milky ^a   Nurmi, Erika L ^a   Laughlin, Christopher P ^a   Morales, Angelica M ^a   Gail, Emma H ^a   Hellemann, Gerhard S ^a   London, Edythe D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; COMT PROTEIN, HUMAN; DRD2 PROTEIN, HUMAN; DRD3 PROTEIN, HUMAN; DRD4 PROTEIN, HUMAN; SLC6A3 PROTEIN, HUMAN;

ADULT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DECISION MAKING; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC VARIABILITY; HUMAN; MALE; MIDDLE FRONTAL GYRUS; NORMAL HUMAN; PARIETAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEX DIFFERENCE; ADOLESCENT; BRAIN MAPPING; GENETIC VARIATION; GENETICS; HIGH RISK BEHAVIOR; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN MAPPING; CATECHOL O-METHYLTRANSFERASE; DECISION MAKING; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENETIC VARIATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; RISK-TAKING; YOUNG ADULT;

EID: 84953911754     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.192     Document Type: Article

References (64)

1. Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE (2003). Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 23: 2008-2013.
2. Arvidsson E, Viereckel T, Mikulovic S, Wallen-Mackenzie A (2014). Age-and sex-dependence of dopamine release and capacity for recovery identified in the dorsal striatum of C57/Bl6J mice. PLoS One 9: E99592.
3. Bilder RM, Volavka J, Lachman HM, Grace AA (2004). The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29: 1943-1961.
4. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P et al (2004). Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161: 1211-1218.
5. Centonze D, Gubellini P, Pisani A, Bernardi G, Calabresi P (2003). Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Rev Neurosci 14: 207-216.
6. Cepeda C, Hurst RS, Altemus KL, Flores-Hernandez J, Calvert CR, Jokel ES et al (2001). Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol 85: 659-670.
7. Cook EHJr, SteinMA, KrasowskiMD,CoxNJ, OlkonDM,Kieffer JE et al (1995). Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56: 993-998.
8. Cools R (2008). Role of dopamine in the motivational and cognitive control of behavior. Neuroscientist 14: 381-395.
9. Cools R, D'Esposito M (2011). Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry 69: E113-e125.
10. Cools R, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M (2008). Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci 28: 1208-1212.
11. Dalley JW, Everitt BJ, Robbins TW (2011). Impulsivity, compulsivity, and top-down cognitive control. Neuron 69: 680-694.
12. De Mei C, Ramos M, Iitaka C, Borrelli E (2009). Getting specialized: Presynaptic and postsynaptic dopamine D2 receptors. Curr Opin Pharmacol 9: 53-58.
13. DeVito EE, Blackwell AD, Kent L, Ersche KD, Clark L, Salmond CH et al (2008). The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder. Biol Psychiatry 64: 636-639.
14. Di Paolo T (1994). Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 5: 27-41.
15. Dreyer JK, Hounsgaard J (2012). Mathematical model of dopamine autoreceptors and uptake inhibitors and their influence on tonic and phasic dopamine signaling. J Neurophysiol 109: 171-182.
16. Ernst M, Paulus MP (2005). Neurobiology of decision making: A selective review from a neurocognitive and clinical perspective. Biol Psychiatry 58: 597-604.
17. Faraone SV, Spencer TJ, Madras BK, Zhang-James Y, Biederman J (2013). Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: A metaanalysis. Mol Psychiatry 19: 880-889.
18. Floresco SB, Tse MT, Ghods-Sharifi S (2008). Dopaminergic and glutamatergic regulation of effort-and delay-based decision making. Neuropsychopharmacology 33: 1966-1979.
19. Frank MJ, Loughry B, O'Reilly RC (2001). Interactions between frontal cortex and basal ganglia in working memory: A computational model. Cogn Affect Behav Neurosci 1: 137-160.
20. Frank MJ, Scheres A, Sherman SJ (2007). Understanding decisionmaking deficits in neurological conditions: Insights from models of natural action selection. Philos Trans R Soc Lond B Biol Sci 362: 1641-1654.
21. Gonzalez S, Rangel-Barajas C, Peper M, Lorenzo R, Moreno E, Ciruela F et al (2012). Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain. Mol Psychiatry 17: 650-662.
22. Grace AA (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience 41: 1-24.
23. Gurvich C, Rossell SL (2015). Dopamine and cognitive control: Sexby-genotype interactions influence the capacity to switch attention. Behav Brain Res 281: 96-101.
24. Hartung CM, Willcutt EG, Lahey BB, Pelham WE, Loney J, Stein MA et al (2002). Sex differences in young children who meet criteria for attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol 31: 453-464.
25. Hellstrand M, Danielsen EA, Steen VM, Ekman A, Eriksson E, Nilsson CL (2004). The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells. J Med Genet 41: 867-871.
26. Jentsch JD, Taylor JR (1999). Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 146: 373-390.
27. Johnson SW, Seutin V, North RA (1992). Burst firing in dopamine neurons induced by N-methyl-D-aspartate: Role of electrogenic sodium pump. Science 258: 665-667.
28. Kaasinen V, Nagren K, Hietala J, Farde L, Rinne JO (2001). Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain. Am J Psychiatry 158: 308-311.
29. Khan ZU, Mrzljak L, Gutierrez A, de la Calle A, Goldman-Rakic PS (1998). Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci USA 95: 7731-7736.
30. Kilford EJ, Dumontheil I, Wood NW, Blakemore SJ (2014). Influence of COMT genotype and affective distractors on the processing of self-generated thought. Soc Cogn Affect Neurosci 10: 777-782.
31. KohnoM, Ghahremani DG, Morales AM, Robertson CL, Ishibashi K, Morgan AT et al (2013). Risk-taking behavior: Dopamine D2/D3 receptors, feedback, and frontolimbic activity. Cereb Cortex 25: 236-245.
32. Kohno M, Morales AM, Ghahremani DG, Hellemann G, London ED (2014). Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence. JAMA Psychiatry 71: 812-820.
33. Krain AL, Wilson AM, Arbuckle R, Castellanos FX, Milham MP (2006). Distinct neural mechanisms of risk and ambiguity: A meta-analysis of decision-making. NeuroImage 32: 477-484.
34. Lancaster TM, Linden DE, Heerey EA (2012). COMT val158met predicts reward responsiveness in humans. Genes Brain Behav 11: 986-992.
35. Lauzon NM, Laviolette SR (2010). Dopamine D4-receptor modulation of cortical neuronal network activity and emotional processing: Implications for neuropsychiatric disorders. Behav Brain Res 208: 12-22.
36. Le Foll B, Guranda M, Wilson AA, Houle S, Rusjan PM, Wing VC et al (2013). Elevation of dopamine induced by cigarette smoking: Novel insights from a [11C]-+PHNO PET study in humans. Neuropsychopharmacology 39: 415-424.
37. Levine MS, Cepeda C (1998). Dopamine modulation of responses mediated by excitatory amino acids in the neostriatum. Adv Pharmacol 42: 724-729.
38. Lippert RN, Ellacott KL, Cone RD (2014). Gender-specific roles for the melanocortin-3 receptor in the regulation of the mesolimbic dopamine system in mice. Endocrinology 155: 1718-1727.
39. Mata R, Hau R, Papassotiropoulos A, Hertwig R (2012). DAT1 polymorphism is associated with risk taking in the Balloon Analogue Risk Task (BART). PLoS One 7: E39135.
40. McGeer PL, McGeer EG, Scherer U, Singh K (1977). A glutamatergic corticostriatal path? Brain Res 128: 369-373.
41. Meltzer HY (1980). Relevance of dopamine autoreceptors for psychiatry: Preclinical and clinical studies. Schizophr Bull 6: 456-475.
42. Meyer-Lindenberg A, Kohn PD, Kolachana B, Kippenhan S, McInerney-Leo A, Nussbaum R et al (2005). Midbrain dopamine and prefrontal function in humans: Interaction and modulation by COMT genotype. Nat Neurosci 8: 594-596.
43. Nikolova YS, Ferrell RE, Manuck SB, Hariri AR (2011). Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology 36: 1940-1947.
44. Rahman S, JS B, N Cardinal R, Rogers R, Robbins T (2001). Decision making and neuropsychiatry. Trends Cogn Sci 5: 271-277.
45. Rao H, Korczykowski M, Pluta J, Hoang A, Detre JA (2008). Neural correlates of voluntary and involuntary risk taking in the human brain: An fMRI Study of the Balloon Analog Risk Task (BART). NeuroImage 42: 902-910.
46. Riba J, Kramer UM, Heldmann M, Richter S, Munte TF (2008). Dopamine agonist increases risk taking but blunts reward-related brain activity. PLoS One 3: E2479.
47. Riccardi P, Zald D, Li R, Park S, Ansari MS, Dawant B et al (2006). Sex differences in amphetamine-induced displacement of [(18)F] fallypride in striatal and extrastriatal regions: A PET study. Am J Psychiatry 163: 1639-1641.
48. Rudnick G, Clark J (1993). From synapse to vesicle: The reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144: 249-263.
49. Savitz J, Hodgkinson CA, Martin-Soelch C, Shen PH, Szczepanik J, Nugent A et al (2013). The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement. PLoS One 8: E54108.
50. Shaikh S, Collier D, Kerwin RW, Pilowsky LS, Gill M, Xu WM et al (1993). Dopamine D4 receptor subtypes and response to clozapine. Lancet 341: 116.
51. Shiels K, Hawk LW Jr, Reynolds B, Mazzullo RJ, Rhodes JD, Pelham WE Jr et al (2009). Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol 17: 291-301.
52. St Onge JR, Ahn S, Phillips AG, Floresco SB (2012). Dynamic fluctuations in dopamine efflux in the prefrontal cortex and nucleus accumbens during risk-based decision making. J Neurosci 32: 16880-16891.
53. St Onge JR, Floresco SB (2009). Dopaminergic modulation of risk-based decision making. Neuropsychopharmacology 34: 681-697.
54. Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP et al (2001). Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 41: 275-284.
55. Stice E, Yokum S, Burger K, Epstein L, Smolen A (2012). Multilocus genetic composite reflecting dopamine signaling capacity predicts reward circuitry responsivity. J Neurosci 32: 10093-10100.
56. Stopper CM, Tse MT, Montes DR,Wiedman CR, Floresco SB (2014). Overriding phasic dopamine signals redirects action selection during risk/reward decision making. Neuron 84: 177-189.
57. Sugam JA, Day JJ, Wightman RM, Carelli RM (2012). Phasic nucleus accumbens dopamine encodes risk-based decisionmaking behavior. Biol Psychiatry 71: 199-205.
58. Usiello A, Baik JH, Rouge-Pont F, Picetti R, Dierich A, LeMeur M et al (2000). Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408: 199-203.
59. Uzefovsky F, Shalev I, Israel S, Edelman S, Raz Y, Perach-Barzilay N et al (2014). The dopamine D4 receptor gene shows a gendersensitive association with cognitive empathy: Evidence from two independent samples. Emotion 14: 712-721.
60. Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O et al (1992). Multiple dopamine D4 receptor variants in the human population. Nature 358: 149-152.
61. Volkow ND, Chang L, Wang G-J, Fowler JS, Ding Y-S, Sedler M et al (2001). Low level of brain dopamine D2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158: 2015-2021.
62. Wise RA (2002). Brain reward circuitry: Insights from unsensed incentives. Neuron 36: 229-240.
63. Zack M, Poulos CX (2004). Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology 29: 195-207.
64. Zack M, Poulos CX (2007). A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacology 32: 1678-1686.